BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12154092)

  • 1. Rescue of HIV-1 receptor function through cooperation between different forms of the CCR5 chemokine receptor.
    Chelli M; Alizon M
    J Biol Chem; 2002 Oct; 277(42):39388-96. PubMed ID: 12154092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor.
    Chelli M; Alizon M
    J Biol Chem; 2001 Dec; 276(50):46975-82. PubMed ID: 11600494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na+/H+ exchanger regulatory factor-1 is involved in chemokine receptor homodimer CCR5 internalization and signal transduction but does not affect CXCR4 homodimer or CXCR4-CCR5 heterodimer.
    Hammad MM; Kuang YQ; Yan R; Allen H; Dupré DJ
    J Biol Chem; 2010 Nov; 285(45):34653-64. PubMed ID: 20801883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
    Melikyan GB; Platt EJ; Kabat D
    Retrovirology; 2007 Aug; 4():55. PubMed ID: 17686153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
    Hug P; Lin HM; Korte T; Xiao X; Dimitrov DS; Wang JM; Puri A; Blumenthal R
    J Virol; 2000 Jul; 74(14):6377-85. PubMed ID: 10864648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mapping of epitopes for interaction of HIV-1 as well as natural ligands with the chemokine receptors, CCR5 and CXCR4.
    Antonsson L; Boketoft A; Garzino-Demo A; Olde B; Owman C
    AIDS; 2003 Dec; 17(18):2571-9. PubMed ID: 14685051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
    Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
    Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
    Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA
    J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates.
    Thompson DA; Cormier EG; Dragic T
    J Virol; 2002 Mar; 76(6):3059-64. PubMed ID: 11861874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins.
    Hill CM; Kwon D; Jones M; Davis CB; Marmon S; Daugherty BL; DeMartino JA; Springer MS; Unutmaz D; Littman DR
    Virology; 1998 Sep; 248(2):357-71. PubMed ID: 9721244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1.
    Kuhmann SE; Platt EJ; Kozak SL; Kabat D
    J Virol; 2000 Aug; 74(15):7005-15. PubMed ID: 10888639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
    Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T
    J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
    Giroud C; Marin M; Hammonds J; Spearman P; Melikyan GB
    J Virol; 2015 Sep; 89(18):9368-82. PubMed ID: 26136569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
    Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
    J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.